PMN - ProMIS Neurosciences Inc.
11.445
-0.085 -0.743%
Share volume: 57,500
Last Updated: 04-20-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$11.53
-0.08
-0.01%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-12-2025 | 08-13-2025 | 11-12-2025 | 03-25-2026 | |
| Cash flow financing | 0.000 | 0.000 | 20.945 M | -1.000 | |
| Other financing cash flows | 0.000 | 0.000 | 3.050 K | 0.000 | |
| Cash flow | -4.927 M | 0.000 | 0.000 | -9.283 M | |
| Net income | -7.348 M | -10.117 M | -11.580 M | -10.674 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | -702.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -4.927 M | -3.854 M | 10.889 M | -9.283 M |